Recommendation Provides Patient Access to Treatment for Ultra-Rare Condition with Reimbursement
25 November, 2015
MSD (Merck & Co., Inc., Kenilworth, NJ, USA) today announces the availability of Zerbaxa®? (ceftolozane/tazobactam) in the UK, a new intravenous antibiotic for the treatment of complicated intra-abdominal infections (cIAI), acute pyelonephritis and complicated urinary tract infections (cUTI) in hospital settings. Ceftolozane /tazobactam offers an alternative to carbapenems, currently a standard treatment for ESBL-producing organisms which have been linked to the emergence of carbapenem-resistant bacteria contributing to global antimicrobial resistance (AMR)
21 November, 2015
Experts in the field of neurology, psychology, rehabilitation and music therapy will gather at the Royal Society of Medicine in London on Monday 16 November to discuss the use of music interventions in older people with conditions including stroke, dementia, brain injuries and motor disorders.
06 November, 2015